(ADAP) Adaptimmune Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Adaptimmune Therapeutics | (ADAP) share price targets
Complete technical analysis of Adaptimmune Therapeutics (ADAP) by charts plus indicators, forecast predictions and share price targets for Adaptimmune Therapeutics (ADAP)
Adaptimmune Therapeutics trades in USA in Health Care sector.
10 day averaged volume of Adaptimmune Therapeutics is 3696540
Date | Daily Closing Price | Open | High | Low | Volume |
02 Wed Apr 2025 | 0.31 | 0.25 | 0.32 | 0.24 | 1.828 times |
01 Tue Apr 2025 | 0.25 | 0.20 | 0.25 | 0.20 | 1.598 times |
31 Mon Mar 2025 | 0.20 | 0.21 | 0.21 | 0.20 | 0.785 times |
28 Fri Mar 2025 | 0.21 | 0.24 | 0.24 | 0.20 | 0.803 times |
24 Mon Mar 2025 | 0.28 | 0.31 | 0.31 | 0.27 | 0.783 times |
21 Fri Mar 2025 | 0.29 | 0.31 | 0.31 | 0.28 | 1.361 times |
20 Thu Mar 2025 | 0.28 | 0.43 | 0.43 | 0.26 | 3.8 times |
19 Wed Mar 2025 | 0.45 | 0.47 | 0.47 | 0.44 | 0.154 times |
18 Tue Mar 2025 | 0.46 | 0.46 | 0.47 | 0.45 | 0.136 times |
17 Mon Mar 2025 | 0.46 | 0.45 | 0.47 | 0.45 | 0.368 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 0.3 as stoploss in an intra day buy trade for a target of 0.4. However, stock will show a bearish move below 0.3.
Share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Target | 0.20 |
Downside Target | 0.26 |
Downside Target | 0.31 |
Upside Target | 0.32 |
Upside Target | 0.44 |
Upside Target | 0.46 |
Upside Target | 0.47 |
Upside Target | 0.49 |
Upside Target | 0.51 |
Upside Target | 0.53 |
Upside Target | 0.56 |
Upside Target | 0.62 |
Upside Target | 0.67 |
Upside Target | 0.69 |
Intraday share price targets for Adaptimmune Therapeutics (ADAP)
Target Type | Value |
Downside Intraday Target | 0.23 |
Downside Intraday Target | 0.16 |
Upside Intraday Target | 0.35 |
Upside Intraday Target | 0.4 |
Downside Intraday Target | 0.28 |
Weekly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Weekly Closing Price | Open | High | Low | Volume |
02 Wed Apr 2025 | 0.31 | 0.21 | 0.32 | 0.20 | 2.655 times |
28 Fri Mar 2025 | 0.21 | 0.31 | 0.31 | 0.20 | 0.273 times |
21 Fri Mar 2025 | 0.29 | 0.45 | 0.47 | 0.26 | 2.971 times |
14 Fri Mar 2025 | 0.45 | 0.48 | 0.49 | 0.44 | 1.263 times |
07 Fri Mar 2025 | 0.48 | 0.56 | 0.56 | 0.46 | 0.683 times |
Price has moved up this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Adaptimmune Therapeutics (ADAP)
Date | Monthly Closing Price | Open | High | Low | Volume |
02 Wed Apr 2025 | 0.31 | 0.20 | 0.32 | 0.20 | 0.293 times |
31 Mon Mar 2025 | 0.20 | 0.56 | 0.56 | 0.20 | 2.494 times |
28 Fri Feb 2025 | 0.54 | 0.57 | 0.62 | 0.51 | 0.66 times |
31 Fri Jan 2025 | 0.59 | 0.54 | 0.69 | 0.54 | 0.549 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Adaptimmune Therapeutics (ADAP)
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Adaptimmune Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Adaptimmune Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.28 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Adaptimmune Therapeutics ( (ADAP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Adaptimmune Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Adaptimmune Therapeutics in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Adaptimmune Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Adaptimmune Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Adaptimmune Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.28 and Adaptimmune Therapeutics (ADAP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Adaptimmune Therapeutics (ADAP) stock. Volume based technical analysis of Adaptimmune Therapeutics (ADAP) stock is negative.
Adaptimmune Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.